Kyverna Therapeutics, INC. (KYTX) SEC Filings — 2025

Filings

• Kyverna Therapeutics Files 8-K: Material Definitive Agreement — 8-K · Dec 18, 2025
• Kyverna Therapeutics Files 8-K — 8-K · Dec 15, 2025
• Kyverna's Losses Widen Amid Soaring R&D Costs — 10-Q · Nov 12, 2025
• Kyverna Therapeutics, INC. 8-K Filing — 8-K · Nov 3, 2025
• Kyverna Therapeutics Files 8-K — 8-K · Oct 29, 2025
• Kyverna Therapeutics Reports Director/Officer Changes & Financials — 8-K · Sep 25, 2025
• Kyverna's Q2 Loss Widens on Soaring R&D for Autoimmune Therapies — 10-Q · Aug 12, 2025
• Kyverna Therapeutics Files 8-K on Executive & Board Changes — 8-K · Jun 30, 2025
• Kyverna Therapeutics Files 8-K on Shareholder Votes & Financials — 8-K · Jun 3, 2025
• Kyverna Therapeutics Files 10-Q Post-IPO — 10-Q · May 13, 2025
• Kyverna Therapeutics Files 2025 Proxy Statement — DEF 14A · Apr 14, 2025
• Kyverna Therapeutics, INC. 10-K Filing — 10-K · Mar 27, 2025
• Marinus to Acquire Kyverna Therapeutics for $550M — 8-K · Jan 21, 2025
• Kyverna Therapeutics Files 8-K Report — 8-K · Jan 13, 2025